Status:
COMPLETED
Subcutaneous Injection of Erythropoietin on Visual Functions in Patients With Late Onset Optic Neuropathy
Lead Sponsor:
Alexandria University
Conditions:
Optic Neuropathy
Eligibility:
All Genders
18-80 years
Phase:
PHASE1
PHASE2
Brief Summary
This study aimed to investigate the therapeutic effect of subcutaneous erythropoietin in the management of late stage optic neuropathy.
Detailed Description
Injury of the optic nerve or optic neuropathy is one of the most common causes of vision loss. This study aimed to investigate the therapeutic effect of subcutaneous erythropoietin in the management o...
Eligibility Criteria
Inclusion
- Patients with late stage optic neuropathy (1 month to 12 months after onset of optic neuropathy due to late referral of the cases)
Exclusion
- Patients with perforating ocular injuries were excluded.
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04469777
Start Date
April 1 2019
End Date
December 30 2020
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alexandria Faculty of Medicine
Alexandria, Egypt